Fresenius moves early to de-risk M&A
Fresenius, the German healthcare company, launched a €1.014bn top-up placement on Thursday evening, moving quickly to issue straight equity rather than an equity-linked product to help pay for a recent acquisition.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts